American Century Companies Portfolio holdings
American Century Companies, Inc., founded in 1958 by James E. Stowers Jr. as Twentieth Century Mutual Funds and headquartered in Kansas City, Missouri, is a privately held investment management firm renowned for its focus on delivering investment results to clients while supporting medical research. Starting with just $100,000 from 24 shareholders, it rebranded to American Century Investments in 1997 and now manages hundreds of billions in assets across mutual funds, ETFs, and institutional portfolios, emphasizing no-load funds and a client-centric approach. The firm’s unique ownership structure sees over 40% of its profits funneled to the Stowers Institute for Medical Research, which it majority-owns, funding groundbreaking biomedical research, while Nomura Holdings holds a significant minority stake. With a global presence in cities like New York, London, and Hong Kong, and a workforce of around 1,400, American Century blends financial expertise with a mission to improve lives through both wealth creation and scientific advancement.
Top Buys
| 1 |
NVIDIA
NVDA
|
+$311M |
| 2 |
Humana
HUM
|
+$270M |
| 3 |
Meta Platforms (Facebook)
META
|
+$256M |
| 4 |
Colgate-Palmolive
CL
|
+$163M |
| 5 |
iShares Russell Mid-Cap Value ETF
IWS
|
+$160M |
Top Sells
| 1 |
Amazon
AMZN
|
+$653M |
| 2 |
Microsoft
MSFT
|
+$614M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$348M |
| 4 |
L3Harris
LHX
|
+$242M |
| 5 |
Idexx Laboratories
IDXX
|
+$238M |
Sector Composition
| 1 | Technology | 22.01% |
| 2 | Healthcare | 14.17% |
| 3 | Financials | 13.99% |
| 4 | Consumer Discretionary | 11.07% |
| 5 | Industrials | 9.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2501
Anywhere Real Estate
HOUS
$800M
| $80.2K | ﹤0.01% |
19,379
+9,363
| +93% | +$38.7K |
|
2502
iHeartMedia
IHRT
$389M
| $79.2K | ﹤0.01% |
21,283
+7,689
| +57% | +$28.6K |
|
2503
Archer Aviation
ACHR
$5.64B
| $77K | ﹤0.01% |
27,996
+6,313
| +29% | +$17.4K |
|
2504
Sangamo Therapeutics
SGMO
$152M
| $75.7K | ﹤0.01% |
44,546
+4,307
| +11% | +$7.32K |
|
|
FSR
2505
DELISTED
Fisker Inc.
FSR
| $75.5K | ﹤0.01% |
+12,630
| New | +$75.5K |
|
2506
Kodak
KODK
$486M
| $72.4K | ﹤0.01% |
17,486
+2,589
| +17% | +$10.7K |
|
2507
Tile Shop Holdings
TTSH
$273M
| $71.3K | ﹤0.01% |
15,603
+1,734
| +13% | +$7.92K |
|
2508
Ardelyx
ARDX
$1.59B
| $71K | ﹤0.01% |
+15,475
| New | +$71K |
|
|
PTRA
2509
DELISTED
Proterra Inc. Common Stock
PTRA
| $69.5K | ﹤0.01% |
46,053
+10,102
| +28% | +$15.3K |
|
2510
Altice USA
ATUS
$1.12B
| $69.3K | ﹤0.01% |
21,944
-79,874
| -78% | -$252K |
|
2511
Sutro Biopharma
STRO
$74.3M
| $65.7K | ﹤0.01% |
14,656
+1,833
| +14% | +$8.21K |
|
2512
Ardagh Metal Packaging
AMBP
$2.13B
| $64.5K | ﹤0.01% |
16,085
+390
| +2% | +$1.56K |
|
|
DNMR
2513
DELISTED
Danimer Scientific, Inc.
DNMR
| $63.9K | ﹤0.01% |
518
+87
| +20% | +$10.7K |
|
2514
Atara Biotherapeutics
ATRA
$85.1M
| $63.3K | ﹤0.01% |
905
+302
| +50% | +$21.1K |
|
2515
Atea Pharmaceuticals
AVIR
$249M
| $62.2K | ﹤0.01% |
19,034
+1,671
| +10% | +$5.46K |
|
2516
Butterfly Network
BFLY
$395M
| $61.5K | ﹤0.01% |
37,525
+6,948
| +23% | +$11.4K |
|
|
CO
2517
DELISTED
Global Cord Blood Corporation
CO
| $61.5K | ﹤0.01% |
20,591
| – | – |
|
|
NIU
2518
Niu Technologies
NIU
$316M
| $61.1K | ﹤0.01% |
15,226
+3
| +0% | +$12 |
|
2519
Adicet Bio
ACET
$67.5M
| $59.7K | ﹤0.01% |
+10,220
| New | +$59.7K |
|
|
MTTR
2520
DELISTED
Matterport, Inc. Class A Common Stock
MTTR
| $58.1K | ﹤0.01% |
22,164
+1,098
| +5% | +$2.88K |
|
|
QVCGA
2521
QVC Group, Inc. Series A Common Stock
QVCGA
$92M
| $57.4K | ﹤0.01% |
1,303
+405
| +45% | +$17.9K |
|
2522
Sana Biotechnology
SANA
$828M
| $57.4K | ﹤0.01% |
18,465
+7,734
| +72% | +$24.1K |
|
2523
Fulcrum Therapeutics
FULC
$379M
| $57.2K | ﹤0.01% |
+20,203
| New | +$57.2K |
|
|
TUYA
2524
Tuya Inc
TUYA
$1.57B
| $55.7K | ﹤0.01% |
29,178
+12,155
| +71% | +$23.2K |
|
2525
AvePoint
AVPT
$3.31B
| $55.1K | ﹤0.01% |
+13,925
| New | +$55.1K |
|